Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMVT Immunovant > Detailed Quotes

IMVT Immunovant

4.580
+0.060+1.33%
Trading Session 09/27 14:15 ET
High
4.780
Open
4.550
Turnover
603.95K
Low
4.495
Pre Close
4.520
Volume
129.89K
Market Cap
533.92M
P/E(TTM)
Loss
52wk High
9.535
Shares
116.58M
P/E(Static)
Loss
52wk Low
3.145
Float Cap
152.60M
Bid/Ask %
20.00%
Historical High
53.750
Shs Float
33.32M
Volume Ratio
0.44
Historical Low
3.145
Dividend TTM
--
Div Yield TTM
--
P/B
1.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.39%
Amplitude
6.31%
Avg Price
4.649
Lot Size
1
Float Cap
152.60M
Bid/Ask %
20.00%
Historical High
53.750
Shs Float
33.32M
Volume Ratio
0.44
Historical Low
3.145
Dividend TTM
--
P/B
1.22
Dividend LFY
--
Turnover Ratio
0.39%
Amplitude
6.31%
Avg Price
4.649
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Immunovant, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.
CEO: Dr. Peter Salzmann, M.B.A.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...